Antiresorptive Use and Risk of Hip Fracture in Older Women with Osteoporosis: Findings from a Real-World National Database of 21,332 Women
Background: Evidence on the real-world effectiveness of antiresorptive therapy for hip fracture prevention in very old women remains limited. We aimed to assess the association between antiresorptive use and incident hip fracture among age ≥ 75 older women with osteoporosis. Methods: We conducted a population-based nes...